Colon cancer antigen panel
US6794501B2 · kind B2 · utility
17Cited by
7References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 4, 2001 |
| Grant date | Sep 21, 2004 |
| Priority date | — |
| Expiry date | Jul 31, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for diagnosing cancer including colon cancer, based on the identification of certain colon cancer-associated polypeptides as antigens that elicit immune responses in colon cancer. The identified antigens can be utilized as markers for diagnosing colon cancer, and for following the course of treatment of colon cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.